Skip to main content

Apollomics Inc.

APLM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001944885

In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 4 institutions reported holding it in 13F filings for Q2 2026, worth $223.8K in total; no superinvestor holds it.

Other share classesAPLMW

Q4 2024 vs. Q3 2024

How the institutions holding Apollomics Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of APLM: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders115−6
Shares2.27M12.8K−2.26M (−99.4%)
Value$323.1K$129.0K−$194.1K (−60.1%)

New holders (2)

Institutions that held Apollomics Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to APLM in Q4 2024
InstitutionSharesValue% of portfolio
Tower Research Capital LLC (TRC)37$3610.00%
SBI Securities Co., Ltd.15$1460.00%

Sold out (8)

Institutions that held Apollomics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of APLM in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Citadel Advisors LLC542,874$77.2K
Powell Investment Advisors, LLC130,297$18.5K
XTX Topco Ltd68,171$9.69K
Geode Capital Management, LLC57,224$8.14K
Bensler, LLC25,088$3.57K
Warberg Asset Management LLC23,513$3.34K
Commonwealth Equity Services, LLC20,000$3.00K
Jane Street Group, LLC13,391$1.90K